Susan Coakley

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
e19091 Background: Combining bevacizumab (Bev) with platinum doublet yields a survival benefit in previously untreated patients with advanced nonsquamous non-small cell lung cancer. Carboplatin with(More)
  • 1